Related Experiment Video
Updated: Jul 7, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Inhibition of Cdc7/Dbf4 kinase activity affects specific phosphorylation sites on MCM2 in cancer cells
Deborah H Charych1, Mazie Coyne, Asha Yabannavar
1Novartis Institute of Biomedical Research, Oncology, Emeryville, California 94608, USA. deb.charych@fiveprime.com
Abstract:
The Cdc7/Dbf4 kinase is required for initiation of DNA replication and also plays a role in checkpoint function in response to replication stress. Exactly how Cdc7/Dbf4 mediates those activities remains to be elucidated. Cdc7/Dbf4 physically interacts with and phosphorylates the minichromosome maintenance complex (MCM), such as MCM2, MCM4 and MCM6. Cdc7/Dbf4 activity is required for association of Cdc45 followed by recruitment of DNA polymerase on the chromatin. Using high resolution mass spectrometry, we identified six phosphorylation sites on MCM2, two of them have not been described before. We provide evidence that Cdc7/Dbf4 mediates phosphorylation on serine 108 and serine 40 on human MCM2 in vitro and in vivo in cancer cells in the absence of DNA damage. Antibodies specific to pS108 or pS40 confirmed the sites and established useful read-outs for inhibition of Cdc7/Dbf4. This report demonstrates the utility of an in vitro to in vivo workflow utilizing immunoprecipitation and mass spectrometry to map phosphorylation sites on endogenous kinase substrates. The approach can be readily generalized to identify target modulation read-outs for other potential kinase cancer targets.
Insights
Researchers identified new phosphorylation sites on MCM2, crucial for DNA replication initiation. This discovery provides novel read-outs for targeting Cdc7/Dbf4 kinase in cancer therapy.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- The Cdc7/Dbf4 kinase complex is essential for initiating DNA replication and maintaining genomic stability during replication stress.
- Its precise mechanisms of action, particularly its interaction with the minichromosome maintenance (MCM) complex, require further elucidation.
- Cdc7/Dbf4 is known to phosphorylate MCM proteins, influencing DNA replication progression.
Purpose of the Study:
- To identify novel phosphorylation sites on the MCM2 protein mediated by the Cdc7/Dbf4 kinase.
- To develop specific antibodies against these novel phosphorylation sites as potential biomarkers for Cdc7/Dbf4 activity.
- To validate an in vitro to in vivo workflow for mapping kinase substrate phosphorylation sites.
Main Methods:
- High-resolution mass spectrometry was employed to identify phosphorylation sites on MCM2.
- In vitro kinase assays and analysis of cancer cell lines were used to confirm phosphorylation events.
- Development and validation of phospho-specific antibodies (pS108 and pS40) for MCM2.
Main Results:
- Six phosphorylation sites on human MCM2 were identified, with two previously undescribed.
- Cdc7/Dbf4 was confirmed to mediate phosphorylation at serine 108 (S108) and serine 40 (S40) on MCM2.
- Phospho-specific antibodies for pS108 and pS40 MCM2 were generated, serving as reliable indicators of Cdc7/Dbf4 activity.
Conclusions:
- This study elucidates specific MCM2 phosphorylation events regulated by Cdc7/Dbf4, advancing the understanding of DNA replication initiation.
- The developed phospho-specific antibodies offer valuable tools for monitoring Cdc7/Dbf4 kinase activity in cancer research and therapeutic development.
- The presented workflow provides a generalizable method for identifying and validating phosphorylation sites on kinase substrates.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Abnormal Proliferation
Anaphase Promoting Complex
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
DNA Damage can Stall the Cell Cycle
